|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/03/22 Artemis Therapeutics, Inc. 10-K 12/31/21 44:2.6M Z-K Global Ltd./FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 477K
2: EX-4.2 Description of Securities HTML 21K
3: EX-31.1 Certification of Principal Executive Officer and HTML 18K
Principal Financial Officer
4: EX-32.1 Certifications of Principal Executive Officer and HTML 15K
Principal Financial Officer
10: R1 Document and Entity Information HTML 82K
11: R2 Interim Condensed Consolidated Balance Sheets HTML 88K
12: R3 Interim Condensed Consolidated Balance Sheets HTML 34K
(Parenthetical)
13: R4 Interim Condensed Consolidated Statements of HTML 45K
Comprehensive (Loss) (Unaudited)
14: R5 Interim Condensed Statements of Stockholders' HTML 38K
Equity (Unaudited)
15: R6 Interim Condensed Consolidated Statement of Cash HTML 52K
Flows (Unaudited)
16: R7 General HTML 24K
17: R8 Significant Accounting Policies HTML 31K
18: R9 Commitments and Contingencies HTML 19K
19: R10 Income Tax HTML 40K
20: R11 Warrants Issued to Investors HTML 19K
21: R12 Computation of Net Loss per Share HTML 31K
22: R13 Stock Capital HTML 58K
23: R14 Related Parties HTML 18K
24: R15 Subsequent Events HTML 17K
25: R16 Significant Accounting Policies (Policies) HTML 51K
26: R17 Income Tax (Tables) HTML 34K
27: R18 Warrants Issued to Investors (Tables) HTML 20K
28: R19 Computation of Net Loss per Share (Tables) HTML 29K
29: R20 Stock Capital (Tables) HTML 50K
30: R21 Commitments and Contingencies (Details) HTML 21K
31: R22 Income Tax (Narrative) (Details) HTML 22K
32: R23 Income Tax (Schedule of Deferred Income Taxes) HTML 20K
(Details)
33: R24 Income Tax (Schedule of Net Operating Loss HTML 21K
Carryforwards) (Details)
34: R25 Warrants Issued to Investors (Details) HTML 21K
35: R26 Computation of Net Loss per Share (Schedule of HTML 39K
Calculation of Basic Loss Per Share) (Details)
36: R27 Stock Capital (Narrative) (Details) HTML 41K
37: R28 Stock Capital (Summary of Stock Option Activity) HTML 38K
(Details)
38: R29 Stock Capital (Summary of Stock Option Exercise HTML 34K
price) (Details)
39: R30 Related Parties (Narrative) (Details) HTML 33K
42: XML IDEA XML File -- Filing Summary XML 72K
40: XML XBRL Instance -- zk2227387_htm XML 459K
41: EXCEL IDEA Workbook of Financial Reports XLSX 41K
6: EX-101.CAL XBRL Calculations -- atms-20211231_cal XML 52K
7: EX-101.DEF XBRL Definitions -- atms-20211231_def XML 162K
8: EX-101.LAB XBRL Labels -- atms-20211231_lab XML 511K
9: EX-101.PRE XBRL Presentations -- atms-20211231_pre XML 316K
5: EX-101.SCH XBRL Schema -- atms-20211231 XSD 80K
43: JSON XBRL Instance as JSON Data -- MetaLinks 178± 236K
44: ZIP XBRL Zipped Folder -- 0001178913-22-000921-xbrl Zip 106K
 | Download this zipped .zip folder |
| Files: | atms-20211231.xsd atms-20211231_cal.xml atms-20211231_def.xml atms-20211231_lab.xml atms-20211231_pre.xml exhibit_31-1.htm exhibit_32-1.htm exhibit_4-2.htm zk2227387.htm |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/10/21 Manuka, Inc. 10-Q 9/30/21 44:2.8M Z-K Global Ltd./FA 8/19/19 Manuka, Inc. 10-Q 6/30/19 43:2.4M Z-K Global Ltd./FA 10/25/17 Manuka, Inc. 8-K:1,3,5,910/25/17 4:558K Z-K Global Ltd./FA 8/29/16 Manuka, Inc. 8-K:1,2,3,5 8/29/16 5:1M Z-K Global Ltd./FA 8/09/11 Artemis Therapeutics, Inc. DEF 14A 8/09/11 1:626K Z-K Global Ltd./FA 9/24/10 Artemis Therapeutics, Inc. 8-K:5,9 9/24/10 5:52K Z-K Global Ltd./FA 4/04/08 Artemis Therapeutics, Inc. 8-K:5,9 4/04/08 2:5K Z-K Global Ltd./FA 11/14/02 Artemis Therapeutics, Inc. 10QSB 9/30/02 6:113K Bowne & C… Smartedgar/FA |